Sponsor Pipeline

Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06931990 A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158… Atopic Dermatitis (AD) Not Yet Recruiting
NCT06932003 A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158… Hidradenitis Suppurativa (HS) Not Yet Recruiting
Phase 1
NCT06082323 A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult… Healthy Volunteer Recruiting
NCT07624214 Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors Non-small Cell Lung Cancer (NSCLC) Not Yet Recruiting
Disease Areas
Get alerts when Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free